These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 32324428)

  • 1. The Potential Health Care Costs And Resource Use Associated With COVID-19 In The United States.
    Bartsch SM; Ferguson MC; McKinnell JA; O'Shea KJ; Wedlock PT; Siegmund SS; Lee BY
    Health Aff (Millwood); 2020 Jun; 39(6):927-935. PubMed ID: 32324428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic Impacts of the COVID-19 Crisis: An Orthopaedic Perspective.
    Anoushiravani AA; O'Connor CM; DiCaprio MR; Iorio R
    J Bone Joint Surg Am; 2020 Jun; 102(11):937-941. PubMed ID: 32496743
    [No Abstract]   [Full Text] [Related]  

  • 3. Medical costs of keeping the US economy open during COVID-19.
    Chen J; Vullikanti A; Hoops S; Mortveit H; Lewis B; Venkatramanan S; You W; Eubank S; Marathe M; Barrett C; Marathe A
    Sci Rep; 2020 Oct; 10(1):18422. PubMed ID: 33116179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study Group.
    Fowler MB; Vera-Llonch M; Oster G; Bristow MR; Cohn JN; Colucci WS; Gilbert EM; Lukas MA; Lacey MJ; Richner R; Young ST; Packer M
    J Am Coll Cardiol; 2001 May; 37(6):1692-9. PubMed ID: 11345386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The COVID-19 Pandemic and the $16 Trillion Virus.
    Cutler DM; Summers LH
    JAMA; 2020 Oct; 324(15):1495-1496. PubMed ID: 33044484
    [No Abstract]   [Full Text] [Related]  

  • 6. Spatiotemporal analysis of medical resource deficiencies in the U.S. under COVID-19 pandemic.
    Sha D; Miao X; Lan H; Stewart K; Ruan S; Tian Y; Tian Y; Yang C
    PLoS One; 2020; 15(10):e0240348. PubMed ID: 33052956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of coronavirus disease 2019 in Shandong, China: a cost and affordability analysis.
    Li XZ; Jin F; Zhang JG; Deng YF; Shu W; Qin JM; Ma X; Pang Y
    Infect Dis Poverty; 2020 Jun; 9(1):78. PubMed ID: 32600426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic aspects of severe sepsis: a review of intensive care unit costs, cost of illness and cost effectiveness of therapy.
    Burchardi H; Schneider H
    Pharmacoeconomics; 2004; 22(12):793-813. PubMed ID: 15294012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covid-19 pandemic and Nepal.
    Atreya A; Nepal B
    Med Leg J; 2020 Jul; 88(2):102-103. PubMed ID: 32427512
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19 and Underinvestment in the Health of the US Population.
    Maani N; Galea S
    Milbank Q; 2020 Jun; 98(2):239-249. PubMed ID: 32333451
    [No Abstract]   [Full Text] [Related]  

  • 11. Hospital Cost Structure and the Implications on Cost Management During COVID-19.
    Bai G; Zare H
    J Gen Intern Med; 2020 Sep; 35(9):2807-2809. PubMed ID: 32607935
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary Care Practice Finances In The United States Amid The COVID-19 Pandemic.
    Basu S; Phillips RS; Phillips R; Peterson LE; Landon BE
    Health Aff (Millwood); 2020 Sep; 39(9):1605-1614. PubMed ID: 32584605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic burden of illness imposed by severe sepsis in Austria.
    Schmid A; Schneider H; Adlof A; Smolle KH; Edelmann G; Sporn P; Frass M; Sumann G; Koller W; Schobersberger W
    Wien Klin Wochenschr; 2002 Aug; 114(15-16):697-701. PubMed ID: 12602114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between BMI and hospital resource use in patients hospitalised for COVID-19 in England: a community-based cohort study.
    Altunkaya J; Piernas C; Pouwels KB; Jebb SA; Clarke P; Astbury NM; Leal J
    Lancet Diabetes Endocrinol; 2024 Jul; 12(7):462-471. PubMed ID: 38843849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inpatient Hospital Costs for COVID-19 Patients in the United States.
    Ohsfeldt RL; Choong CK; Mc Collam PL; Abedtash H; Kelton KA; Burge R
    Adv Ther; 2021 Nov; 38(11):5557-5595. PubMed ID: 34609704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs of healthcare-associated infections to the Brazilian public Unified Health System in a tertiary-care teaching hospital: a matched case-control study.
    Osme SF; Almeida APS; Lemes MF; Barbosa WO; Arantes A; Mendes-Rodrigues C; Gontijo Filho PP; Ribas RM
    J Hosp Infect; 2020 Oct; 106(2):303-310. PubMed ID: 32693085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covid-19 and the documented failure of the American illness profit system - We have to stop treating our doctors, nurses, healthcare workers, and ourselves this way.
    Schwartz SA
    Explore (NY); 2020; 16(4):210-213. PubMed ID: 32461101
    [No Abstract]   [Full Text] [Related]  

  • 18. Financial Burden of Hospitalization of Children with Coronavirus Disease 2019 under the National Health Insurance Service in Korea.
    Lee JK; Kwak BO; Choi JH; Choi EH; Kim JH; Kim DH
    J Korean Med Sci; 2020 Jun; 35(24):e224. PubMed ID: 32567260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden of illness associated with overweight and obesity in patients hospitalized with COVID-19 in the United States: analysis of the premier healthcare database from April 1, 2020 to October 31, 2020.
    Kim N; Aly A; Craver C; Garvey WT
    J Med Econ; 2023; 26(1):376-385. PubMed ID: 36812069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surprise Billing in Surgical Care Episodes - Overview, Ethical Concerns, and Policy Solutions in Light of COVID-19.
    Sheckter CC; Singh P; Angelos P; Offodile AC
    Ann Surg; 2020 Oct; 272(4):e264-e265. PubMed ID: 32520741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.